XSHE
300886
Market cap265mUSD
Oct 09, Last price
23.14CNY
1D
-2.03%
1Q
3.95%
IPO
-61.43%
Name
Anhui Hyea Aromas Co Ltd
Chart & performance
P/E
57.52
P/S
4.67
EPS
0.40
Div yield, %
0.63%
Shrs. gr., 5y
0.07%
Rev. gr., 5y
8.60%
Revenues
372m
+7.83%
Net income
30m
+36.79%
CFO
16m
-20.36%
Dividend
Jul 06, 20260.049787 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Anhui Hyea Aromas Co., Ltd. primarily focuses on the innovation, manufacturing, and market distribution of specialized chemical compounds. The firm's extensive product line includes aldehydes such as peach and coconut, alongside a variety of gamma-lactones, specifically decalactone, octanolactone, caprolactone, enantholactone, dodecolacton, and valerolactone. Furthermore, they provide butyl decanolide, butyldodecalactone, butyloctolactone, butyl-nonolactone, and butyl undecolactone. This enterprise, established in 2002, operates from its central location in Qianshan, China.
Key people
Wenliang Hua
Chairman of the Board · since 2024
Xiayun Xu
Chief Financial Officer · since 2024
Ming Gao
Deputy General Manager · since 2025
Tianyi Wang
Deputy General Manager · since 2024
Yan Wang
Deputy General Manager · since 2024
Xu Wu
Deputy General Manager, Director · since 2021
Liang Chen
Deputy General Manager, Secretary of the Board · since 2024
Yiyi Fan
Chief Engineer, Director
Minfu Wang
Deputy General Manager, Director · since 2024
Yang Wang
Staff Elected Director · since 2025
Jiping Xu
General Manager, Director · since 2024
Guangyang Wu
Independent Director · since 2024
Yunjin Yao
Independent Director · since 2021
Independent Director · since 2024
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||